PTC Therapeutics (PTCT) Earnings
|
Expand Research on PTCT
| Next EPS Date | 8/1/24 *Est. | EPS Growth Rate | +36.2% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -161.6% | Revenue Growth Rate | -4.7% *Last Qtr. |
| Average % Move 1-Wk after EPS | -3.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/25/24 | Q124 | -$1.20 | -$1.29 | +$0.09 | $210.12M | $165.77M | = |  | | Details | |
| 2/29/24 | Q423 | -$2.06 | $0.49 | -$2.55 | $307.1M | $316.48M | = | | | Details | |
| 10/26/23 | Q323 | -$1.76 | -$1.07 | -$0.69 | $196.58M | $210.19M | = | | | Details | |
| 8/3/23 | Q223 | -$2.66 | -$1.58 | -$1.08 | $213.8M | $206.84M | = | | | Details | |
| 4/27/23 | Q123 | -$1.88 | -$1.48 | -$0.40 | $220.4M | $205.47M | = | | | Details | |
| 2/21/23 | Q422 | -$2.35 | -$1.57 | -$0.78 | $167.4M | $190.38M | = | | | Details | |
| 10/27/22 | Q322 | -$1.53 | -$1.31 | -$0.22 | $217.1M | $178.9M | N/A | | | Details | |
| 8/4/22 | Q222 | -$2.13 | -$1.37 | -$0.76 | $166M | $162.12M | = | | | Details |
